This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $1300 | Check With Us |
200mg | $1950 | Check With Us |
500mg | $3290 | Check With Us |
Cat #: V38964 CAS #: 2169919-21-3 Purity ≥ 99%
Description: SNDX-5613 (SNDX5613) is a novel, highly potent and selective inhibitor of Menin-MLL interaction with the potential to be used for MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 630.82 |
---|---|
Molecular Formula | C32H47FN6O4S |
CAS No. | 2169919-21-3 |
SMILES Code | O=C(C1=CC(F)=CC=C1OC2=CN=CN=C2N3CC4(C3)CCN(CC4)C[C@H]5CC[C@@H](CC5)NS(=O)(CC)=O)N(C(C)C)CC |
Synonyms | SNDX5613; SNDX 5613; SNDX-5613; |
Protocol | In Vivo | Revumenib (SNDX-5613) shows in vivo plasma IC50 of 53 nM. Revumenib treatment provides significant survival benefit and leukemic control in aggressive MOLM-13 disseminated xenografts. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.5852 mL | 7.9262 mL | 15.8524 mL | 31.7048 mL |
5mM | 0.3170 mL | 1.5852 mL | 3.1705 mL | 6.3410 mL |
10mM | 0.1585 mL | 0.7926 mL | 1.5852 mL | 3.1705 mL |
20mM | 0.0793 mL | 0.3963 mL | 0.7926 mL | 1.5852 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.